$ACRE
Ares Commercial Real Estate Corp Stock $acre

$acre Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000162828021008723 Filed on May 04, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$21.22M	$21.13M
YoY Change	0.42%	49.28%
Cost Of Revenue	$15.12M	$17.72M
YoY Change	-14.67%	2.37%
Gross Profit	$18.25M	$18.95M
YoY Change	-3.69%	50.64%
Gross Profit Margin	85.99%	89.67%
Selling, General & Admin	$5.340M	$8.870M
YoY Change	-39.8%	128.02%
% of Gross Profit	29.26%	46.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$224.0K	$221.0K
YoY Change	1.36%	309.26%
% of Gross Profit	1.23%	1.17%
Operating Expenses	$2.320M	$36.20M
YoY Change	-93.59%	816.46%
Operating Profit	$15.93M	-$17.25M
YoY Change	-192.35%	-299.88%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$15.93M	-$17.25M
YoY Change	-192.3%	-299.72%
Income Tax	$185.0K	$9.000K
% Of Pretax Income	1.16%
Net Earnings	$15.74M	-$17.26M
YoY Change	-191.18%	-302.07%
Net Earnings / Revenue	74.16%	-81.68%
Basic Earnings Per Share
Diluted Earnings Per Share	$453.3K	-$541.1K
COMMON SHARES
Basic Shares Outstanding	34.42M shares	31.90M shares
Diluted Shares Outstanding	34.72M shares	31.90M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$97.90M	$74.50M
YoY Change	31.41%	482.03%
Cash & Equivalents	$97.94M	$74.50M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$97.90M	$74.50M
YoY Change	31.41%	482.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.10M	$37.90M
YoY Change	-2.11%	2.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$1.871B
YoY Change		20.82%
Other Assets		$400.0K
YoY Change		0.0%
Total Long-Term Assets	$1.993B	$2.027B
YoY Change	-1.68%	26.23%
TOTAL ASSETS
Total Short-Term Assets	$97.90M	$74.50M
Total Long-Term Assets	$1.993B	$2.027B
Total Assets	$2.091B	$2.101B
YoY Change	-0.5%	29.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.60M	$13.90M
YoY Change	26.62%	17.8%
LONG-TERM LIABILITIES
Long-Term Debt	$1.489B	$1.609B
YoY Change	-7.42%	37.21%
Other Long-Term Liabilities	$8.200M	$12.90M
YoY Change	-36.43%	38.71%
Total Long-Term Liabilities	$1.497B	$1.621B
YoY Change	-7.65%	37.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.60M	$13.90M
Total Long-Term Liabilities	$1.497B	$1.621B
Total Liabilities	$1.515B	$1.635B
YoY Change	-7.37%	37.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.63M	-$30.95M
YoY Change	-23.67%	-1296.02%
Common Stock	$599.3M	$497.0M
YoY Change	20.59%	17.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$576.0M	$466.1M
YoY Change
Total Liabilities & Shareholders Equity	$2.091B	$2.101B
YoY Change	-0.5%	29.84%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$15.74M	-$17.26M
YoY Change	-191.18%	-302.07%
Depreciation, Depletion And Amortization	$224.0K	$221.0K
YoY Change	1.36%	309.26%
Cash From Operating Activities	$9.924M	$8.267M
YoY Change	20.04%	21.77%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$200.0K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$131.4M	-$273.7M
YoY Change	-51.99%	2941.11%
Cash From Investing Activities	-$131.4M	-$274.0M
YoY Change	-52.05%	2948.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$144.6M	$334.9M
YoY Change	-56.83%	8441.85%
NET CHANGE
Cash From Operating Activities	$9.924M	$8.267M
Cash From Investing Activities	-$131.4M	-$274.0M
Cash From Financing Activities	$144.6M	$334.9M
Net Change In Cash	$23.17M	$69.24M
YoY Change	-66.54%	3914.03%
FREE CASH FLOW
Cash From Operating Activities	$9.924M	$8.267M
Capital Expenditures	$0.00	-$200.0K
Free Cash Flow	$9.924M	$8.467M
YoY Change	17.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001529377
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-35517
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	ARES COMMERCIAL REAL ESTATE CORPORATION
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-3148087
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	245 Park Avenue
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	42nd Floor
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10167
CY2021Q1	dei	City Area Code CityAreaCode	212
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	750-7300
CY2021Q1	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value per share
CY2021Q1	dei	Trading Symbol TradingSymbol	ACRE
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40501121	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97944000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74776000	USD
CY2021Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1908001000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1815219000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20895000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23604000	USD
CY2021Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest Net MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterestNet	1887106000	USD
CY2020Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest Net MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterestNet	1791615000	USD
CY2021Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	37059000	USD
CY2020Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	37283000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	68694000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	25823000	USD
CY2021Q1	us-gaap	Assets Assets	2090803000	USD
CY2020Q4	us-gaap	Assets Assets	1929497000	USD
CY2021Q1	us-gaap	Line Of Credit LineOfCredit	349582000	USD
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	755552000	USD
CY2021Q1	us-gaap	Notes Payable NotesPayable	40428000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	61837000	USD
CY2021Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	60000000	USD
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	110000000	USD
CY2021Q1	acre	Variable Interest Entity Collateralized Loan Obligation Securities Long Term Debt VariableInterestEntityCollateralizedLoanObligationSecuritiesLongTermDebt	979257000	USD
CY2020Q4	acre	Variable Interest Entity Collateralized Loan Obligation Securities Long Term Debt VariableInterestEntityCollateralizedLoanObligationSecuritiesLongTermDebt	443871000	USD
CY2021Q1	us-gaap	Secured Debt SecuredDebt	59845000	USD
CY2020Q4	us-gaap	Secured Debt SecuredDebt	59790000	USD
CY2021Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3319000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3150000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	14248000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11124000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	8151000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	11158000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1514830000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1456482000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40477841	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40477841	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33442332	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33442332	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	399000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	329000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	598936000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	497803000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	263000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23625000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25117000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	575973000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	473015000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2090803000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1929497000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	30704000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	31448000	USD
CY2021Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	12139000	USD
CY2020Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	15534000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18565000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15914000	USD
CY2021Q1	acre	Operating Revenuefrom Real Estate Owned OperatingRevenuefromRealEstateOwned	2658000	USD
CY2020Q1	acre	Operating Revenuefrom Real Estate Owned OperatingRevenuefromRealEstateOwned	5220000	USD
CY2021Q1	us-gaap	Revenues Revenues	21223000	USD
CY2020Q1	us-gaap	Revenues Revenues	21134000	USD
CY2021Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	2567000	USD
CY2020Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1773000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	785000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	903000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1157000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	868000	USD
CY2021Q1	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	752000	USD
CY2020Q1	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	1051000	USD
CY2021Q1	acre	Operating Expenses From Real Estate Owned OperatingExpensesFromRealEstateOwned	3277000	USD
CY2020Q1	acre	Operating Expenses From Real Estate Owned OperatingExpensesFromRealEstateOwned	6676000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	8538000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	11271000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-3240000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	27117000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15925000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17254000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	185000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	15740000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-17263000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.46
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.54
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.45
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.54
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34417040	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31897952	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34720950	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31897952	shares
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	15740000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-17263000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	263000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16003000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17263000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	426339000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73232000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	341000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	225000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-17263000	USD
CY2020Q1	us-gaap	Dividends Cash DividendsCash	11076000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	466065000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	365000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	9768000	USD
CY2020Q2	us-gaap	Dividends Cash DividendsCash	11072000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	465126000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	367000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	14928000	USD
CY2020Q3	us-gaap	Dividends Cash DividendsCash	11072000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	469349000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	382000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	14407000	USD
CY2020Q4	us-gaap	Dividends Cash DividendsCash	11123000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	473015000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100870000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	188000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1343000	USD
CY2021Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	169000	USD
CY2020Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	27117000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2677000	USD
CY2020Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	75000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1023000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-420000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9924000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8267000	USD
CY2021Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	219205000	USD
CY2020Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	294733000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	87321000	USD
CY2020Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	17471000	USD
CY2021Q1	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	680000	USD
CY2020Q1	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	3538000	USD
CY2021Q1	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	0	USD
CY2020Q1	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	227000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	521000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	263000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	15740000	USD
CY2021Q1	us-gaap	Dividends Cash DividendsCash	14248000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	575973000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	15740000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-17263000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2232000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1622000	USD
CY2021Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	2022000	USD
CY2020Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	1967000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	521000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	225000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	224000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	221000	USD
CY2021Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-3240000	USD
CY2021Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	150000	USD
CY2020Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-131354000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-273951000	USD
CY2021Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	483223000	USD
CY2020Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	93108000	USD
CY2021Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6206000	USD
CY2020Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	27880000	USD
CY2020Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	10555000	USD
CY2021Q1	acre	Payments Of Secured Funding Costs PaymentsOfSecuredFundingCosts	7962000	USD
CY2020Q1	acre	Payments Of Secured Funding Costs PaymentsOfSecuredFundingCosts	1005000	USD
CY2021Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	540471000	USD
CY2020Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	11124000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	9565000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	100870000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	73232000	USD
CY2021Q1	acre	Payments For Offering Costs On Public Offering PaymentsForOfferingCostsOnPublicOffering	13000	USD
CY2020Q1	acre	Payments For Offering Costs On Public Offering PaymentsForOfferingCostsOnPublicOffering	266000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	144598000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	334926000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23168000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69242000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74776000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5635000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97944000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74877000	USD
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. As of the filing date of this Quarterly Report, there is a continued outbreak of the novel coronavirus (“COVID-19”) pandemic, for which the World Health Organization has declared a global pandemic, the United States has declared a national emergency and every state in the United States is under a federal disaster declaration. Many states, including those in which the Company and its borrowers operate, have issued orders requiring the closure of, or certain restrictions on the operation of, non-essential businesses and/or requiring residents to stay at home. The COVID-19 pandemic and preventative measures taken to contain or mitigate its spread have caused, and are continuing to cause, business shutdowns or the re-introduction of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. While several countries, as well as certain states in the United States, have relaxed the public health restrictions with a view to partially or fully reopen their economies, recurring COVID-19 outbreaks have led to the re-introduction of such restrictions in certain states in the United States and globally and could continue to lead to the re-introduction of such restrictions elsewhere.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in December 2020, the U.S. Food and Drug Administration authorized certain vaccines for emergency use, which are currently being distributed nationwide and globally. However, it remains unclear how quickly “herd immunity” will be achieved and the restrictions that were imposed to slow the spread of the virus will be lifted entirely. These uncertainties could lead the public to continue to self-isolate and not participate in the economy at pre-pandemic levels for a prolonged period of time. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and we anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States. The Company believes the estimates and assumptions underlying its consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2021, however, uncertainty over the ultimate impact the COVID-19 pandemic will have on the global economy and the Company’s business, makes any estimates and assumptions as of March 31, 2021 inherently less certain than they would be absent the current and potential impacts of the COVID-19 pandemic. Actual results could differ from those estimates.</span></div>
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97944000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74498000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	379000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97944000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74877000	USD
CY2021Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	12139000	USD
CY2020Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	15534000	USD
CY2021Q1	srt	Mortgage Loans On Real Estate Number Of Loans MortgageLoansOnRealEstateNumberOfLoans	53	loan
CY2021Q1	acre	Mortgage Loans On Real Estate Number Of Loans Repaid Or Sold Since Inception MortgageLoansOnRealEstateNumberOfLoansRepaidOrSoldSinceInception	101	loan
CY2021Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount MortgageLoansOnRealEstateTotalCommitmentAmount	2100000000	USD
CY2021Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount Excluding Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountExcludingNoncontrollingInterest	1900000000	USD
CY2021Q1	acre	Payments To Acquire Loans Held For Investment Including Non Cash Upsize And Excluding Capitalized Funding PaymentsToAcquireLoansHeldForInvestmentIncludingNonCashUpsizeAndExcludingCapitalizedFunding	223400000	USD
CY2021Q1	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	130700000	USD
CY2021Q1	acre	Percentage Of Loans Held For Investment Having Libor Floors PercentageOfLoansHeldForInvestmentHavingLIBORFloors	0.970
CY2021Q1	acre	Loans Receivable Description Of Variable Rate Basis Weighted Average Floor LoansReceivableDescriptionOfVariableRateBasisWeightedAverageFloor	0.0156
CY2021Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1908001000	USD
CY2021Q1	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	1919007000	USD
CY2021Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Including Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldIncludingNonaccrualLoans	0.060
CY2021Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Excluding Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldExcludingNonaccrualLoans	0.062
CY2021Q1	acre	Mortgage Loans On Real Estate Remaining Life MortgageLoansOnRealEstateRemainingLife	P1Y3M18D
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1815219000	USD
CY2020Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	1826241000	USD
CY2020Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Including Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldIncludingNonaccrualLoans	0.063
CY2020Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Excluding Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldExcludingNonaccrualLoans	0.066
CY2020Q1	acre	Mortgage Loans On Real Estate Remaining Life MortgageLoansOnRealEstateRemainingLife	P1Y2M12D
CY2021Q1	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	1919000000.0	USD
CY2021Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1908000000.0	USD
CY2021Q1	acre	Mortgage Loans On Real Estate Unleveraged Effective Yield MortgageLoansOnRealEstateUnleveragedEffectiveYield	0.060
CY2020Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterest	1815219000	USD
CY2021Q1	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	199580000	USD
CY2021Q1	acre	Mortgage Loans On Real Estate Receipt Of Origination Fee MortgageLoansOnRealEstateReceiptOfOriginationFee	1748000	USD
CY2021Q1	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	23864000	USD
CY2021Q1	acre	Mortgage Loans On Real Estate Amortizing Payments MortgageLoansOnRealEstateAmortizingPayments	413000	USD
CY2021Q1	acre	Mortgage Loans On Real Estate Loan Paid Off MortgageLoansOnRealEstateLoanPaidOff	130523000	USD
CY2021Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	2022000	USD
CY2021Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterest	1908001000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	22000000.0	USD
CY2021Q1	acre	Mortgage Loanson Real Estate Commitment Reserveor Allowancefor Credit Loss Basis Points MortgageLoansonRealEstateCommitmentReserveorAllowanceforCreditLossBasisPoints	1.06
CY2021Q1	acre	Commitments Commitments	2100000000	USD
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	451029000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1166755000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	928674000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1249155000	USD
CY2021Q1	acre	Number Of Non Recourse Notes NumberOfNonRecourseNotes	2	loan
CY2021Q1	acre	Debt Issue Discount On Initial Draw Down DebtIssueDiscountOnInitialDrawDown	2600000	USD
CY2020Q1	acre	Number Of Secured Borrowing Arrangements NumberOfSecuredBorrowingArrangements	3	loan
CY2021Q1	us-gaap	Derivative Exchange Rate Floor1 DerivativeExchangeRateFloor1	0.0000
CY2021Q1	acre	Commitments Commitments	2078788000	USD
CY2020Q4	acre	Commitments Commitments	2013993000	USD
CY2021Q1	acre	Funded Commitments FundedCommitments	1919007000	USD
CY2020Q4	acre	Funded Commitments FundedCommitments	1826241000	USD
CY2021Q1	acre	Unfunded Commitments UnfundedCommitments	159781000	USD
CY2020Q4	acre	Unfunded Commitments UnfundedCommitments	187752000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	358682	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	57319	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	301363	shares
CY2021Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestinthe Remainderofthe Year ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestintheRemainderoftheYear	40289	shares
CY2021Q1	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Two ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearTwo	118253	shares
CY2021Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Three ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearThree	89160	shares
CY2021Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Four ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearFour	53661	shares
CY2021Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Five ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearFive	0	shares
CY2021Q1	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants To Date ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsToDate	301363	shares
CY2021Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	15740000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-17263000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34417040	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31897952	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	303910	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34720950	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31897952	shares
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.46
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.54
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.45
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.54
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	223022	shares
CY2021Q1	acre	Excise Taxes Rate ExciseTaxesRate	0.04
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2021Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	658000	USD
CY2020Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	0	USD
CY2021Q1	acre	Related Party Transactions Management Fee Renewal Term RelatedPartyTransactionsManagementFeeRenewalTerm	P1Y
CY2021Q1	acre	Related Party Transactions Termination Fee Based On Average Annual Management And Incentive Fees Ratio RelatedPartyTransactionsTerminationFeeBasedOnAverageAnnualManagementAndIncentiveFeesRatio	3
CY2021Q1	acre	Related Party Transactions Management Fee Look Back Period RelatedPartyTransactionsManagementFeeLookBackPeriod	P24M
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2021Q1	us-gaap	Dividends Dividends	14248000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2021Q1	us-gaap	Dividends Dividends	14248000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	34900000	USD
CY2020Q1	us-gaap	Dividends Dividends	11057000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2020Q1	us-gaap	Dividends Dividends	11057000	USD
CY2021Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.33
CY2021Q1	acre	Common Stock Dividends Per Share Supplemental Cash Dividend CommonStockDividendsPerShareSupplementalCashDividend	0.02
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	6400000	USD
CY2021Q1	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	238200000	USD

Files In Submission

Name	View Source	Status
0001628280-21-008723-index-headers.html	Edgar Link	pending
0001628280-21-008723-index.html	Edgar Link	pending
0001628280-21-008723.txt	Edgar Link	pending
0001628280-21-008723-xbrl.zip	Edgar Link	pending
acre-20210331.htm	Edgar Link	pending
acre-20210331.xsd	Edgar Link	pending
acre-20210331_cal.xml	Edgar Link	unprocessable
acre-20210331_def.xml	Edgar Link	unprocessable
acre-20210331_g1.jpg	Edgar Link	pending
acre-20210331_htm.xml	Edgar Link	completed
acre-20210331_lab.xml	Edgar Link	unprocessable
acre-20210331_pre.xml	Edgar Link	unprocessable
acreq1-21exhibit311.htm	Edgar Link	pending
acreq1-21exhibit312.htm	Edgar Link	pending
acreq1-21exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACRE
Ares Commercial Real Estate Corp Stock $acre

2021 Q1 Form 10-Q Financial Statement

#000162828021008723 Filed on May 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE Ares Commercial Real Estate Corp Stock $acre

2021 Q1 Form 10-Q Financial Statement

#000162828021008723 Filed on May 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE
Ares Commercial Real Estate Corp Stock $acre